Using 99mTc-sestamibi to evaluate the effects of a chemosensitizer on P-glycoprotein in multidrug-resistant carcinoma cells.
Zhang
Zhenwei
Z
Department of Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang
Xuemei
X
Wu
Hua
H
Zhao
Ming
M
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000032:analysis / Q000187:drug effects*; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology; D045744:Cell Line, Tumor; D003627:Data Interpretation, Statistical; D015536:Down-Regulation; D004317:Doxorubicin / Q000494:pharmacology; D018432:Drug Resistance, Multiple / Q000187:drug effects*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D017256:Technetium Tc 99m Sestamibi / Q000032:analysis / Q000493:pharmacokinetics*; D014700:Verapamil / Q000494:pharmacology*
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D004317:Doxorubicin; D017256:Technetium Tc 99m Sestamibi; D014700:Verapamil